Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Public Advisory - Health Canada warns about multiple unauthorized health products that may pose serious health risks


OTTAWA, ON, Aug. 23, 2023 /CNW/ - Health Canada is advising that the following product(s) may pose serious health risks. For more information, including product photos and what you should do, visit these online safety alerts:

Health Canada maintains lists of unauthorized health products that may pose serious health risks so that the public can easily identify those they may have purchased and take appropriate action. You are encouraged to check back regularly for updates.

Product

Hazard Identified

Company

Action Taken

Unauthorized health products for sexual enhancement


3800 Hard Rock

 

 

Product with similar packaging (previously seized) was tested and found to contain tadalafil

Pacific Fresh Food Market

4734 Jane Street, North York, ON

Removed from sale


Black Panther

 

 

Product tested by Health Canada and found to contain tadalafil and sildenafil

Joy's Lucky 7 Food Stop

10639 156 St NW

Edmonton, AB

Seized from retail location


Black Panther Super 500k

 

 

Product tested by Health Canada and found to contain levodopa and prasterone

Joy's Lucky 7 Food Stop
10639 156 St NW

Edmonton, AB

Seized from retail location


Blue Rhino Honey

 

 

Product tested by Health Canada and found to contain tadalafil and sildenafil

Joy's Lucky 7 Food Stop
10639 156 St NW

Edmonton, AB

Seized from retail location


Magnum XXL 500K

 

 

Product tested by Health Canada and found to contain levodopa and prasterone

Joy's Lucky 7 Food Stop
10639 156 St NW

Edmonton, AB

Seized from retail location


Magnum XXL 9800

 

 

Product tested by Health Canada and found to contain levodopa and prasterone

Joy's Lucky 7 Food Stop
10639 156 St NW

Edmonton, AB

Seized from retail location


Rhino 7 Platinum 900K

 

 

Product tested by Health Canada and found to contain levodopa and prasterone

Joy's Lucky 7 Food Stop
10639 156 St NW

Edmonton, AB

Seized from retail location


Rhino X 69 Gold 500k

 

Product tested by Health Canada and found to contain tadalafil

Joy's Lucky 7 Food Stop
10639 156 St NW

Edmonton, AB

Seized from retail location


Rhino X 69 Silver 500K

Product tested by Health Canada and found to contain tadalafil

Joy's Lucky 7 Food Stop
10639 156 St NW

Edmonton, AB

Seized from retail location


Unauthorized health products for treating skin conditions


Betnovate-N Cream

(Skin treatment)

Labelled to contain betamethasone valerate

Global Choice Foods Ltd.

150 Rainbow Creek Drive

Vaughan, ON

Seized from retail location


HADO LABO Gokujyun Hatomugi Blemish + Oil Control

(Skin treatment)

Labelled to contain aminocaproic acid

Sukoshi Mart

1800 Sheppard Ave E

North York, ON

Seized from retail location


HADO LABO Gokujyun Trouble Care Skin Conditioner

(Skin treatment)

Labelled to contain aminocaproic acid

Sukoshi Mart

1800 Sheppard Ave E

North York, ON 

Seized from retail location



Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: